Evista (Raloxifene) for Osteoporosis | MyOsteoTeam

Connect with others who understand.

sign up Log in
About MyOsteoTeam
Powered By

Evista is a prescription medication approved by the Food and Drug Administration (FDA) to treat and prevent osteoporosis in postmenopausal women. Evista may be referred to by its drug name, Raloxifene.

Evista is a selective estrogen receptor modulator (SERM). Evista is believed to work by mimicking the effects of estrogen, which helps protect bone density.

How do I take it?
Evista is taken once daily. Ask your doctor whether you need to take daily calcium and vitamin D supplements while on Evista.

Evista is available as a tablet.

Side effects
The FDA-approved label for Evista lists common side effects including hot flashes and leg cramps.

Rare but serious side effects listed for Evista include venous thromboembolism (potentially life-threatening blood clots in the lungs or leg veins), superficial thrombophlebitis (inflammation caused by blood clots just beneath the skin), increased risk for death due to stroke, and elevated triglycerides (blood fats).

For more details about this treatment, visit:

Evista - RxList

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of use and Privacy policy.
Already a Member? Log in